Synopsis The global Multilayer Co-extruded Films for Food market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukra.....
Synopsis Highlights The global Multilayer Co-extruded Film Infusion Bags market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The i.....
Synopsis Highlights The global Polypropylene Infusion Bags market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of CO.....
Synopsis Highlights The global Low Borosilicate Glass Ampoules market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence o.....
Synopsis Highlights The global Neutral Borosilicate Glass Ampoules market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influen.....
Synopsis Highlights The global Pharmaceutical Oral Liquid Bottles market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influenc.....
Synopsis Highlights The global Pharmaceutical Oral Liquid Glass Bottles market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The in.....
SynopsisThe 4-factor prothrombin complex concentrate (4F-PCC), which contains the human coagulation factors II, VII, IX and X together with the endogenous inhibitor proteins S and C, is indicated for the urgent reversal of acquired coagulation factor deficiency induce.....
SynopsisProthrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not av.....
Synopsis C1 esterase inhibitor is used to treat or prevent hereditary angioedema (HAE). Global C1 Esterase Inhibitor Subcutaneous market is projected to reach US$ 1092 million in 2029, increasing from US$ 612 million in 2022, with the CAGR of 8.7% during the pe.....
